Metrics Invests in New Stability Storage Facility
The company will be investing $3.5 million in a 15,00-square-foot facility in Greenville, North Carolina.
On Aug. 24, 2016, Metrics Contract Services announced that it will be investing $3.5 million in a 15,000-square-foot stability storage expansion that will triple its current capacity in Greenville, North Carolina. The $3.5-million stability storage facility is part of planned expansions at the Greenville campus, Metrics said in a press announcement. Mayne Pharma, the parent company of Metrics, is investing $80 million to expand facilities and equipment, including 10-plus new analytical labs and formulation development suites. Metrics will also introduce commercial-scale manufacturing capability including multi-particulate layering, bead-coating fluid bed technology, and significantly increased capacity to manufacture highly potent products.
Metrics’ expanded stability storage facility is being constructed with automated emergency power generation to ensure integrity of stored samples. System redundancies mean environmental controls remain in place in chambers should a primary conditioner go down. Metrics and Mayne Pharma have committed to hiring 110 new scientists, quality assurance specialists, and other technicians to support expanded operations, increasing their US workforce by more than a third.
Source: Metrics
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
